CagriSema's latest results highlight how obesity drug development is shifting toward multi-mechanism therapies combining complementary biological pathways.
AbbVie joins the AI drug-discovery race with Iambic, applying advanced molecular AI to accelerate small-molecule discovery across core therapeutic areas.
WHO’s new ten-year agenda puts traditional medicine under a stronger evidence test, focusing research on high-burden diseases, safety, and healthcare integration.
On the occasion of World Alzheimer's Day, Yatharth Hospital, Sector 20, Faridabad, has launched the region’s first dedicated Memory Clinic aimed at providing comprehensive assessment, diagnosis and management for individuals experiencing memory loss
Caplyta opens a new chapter for J&J in bipolar treatment as late-stage data support its potential expansion into bipolar mania.
Pharma R&D dollars are spreading across biosimilars, combination therapies, and gene therapy, balancing near-term commercial returns with high-risk innovation.
India is building a wider safety net for transplant medicines with a dedicated Biovigilance Programme to strengthen adverse-event monitoring and patient safety.
World Alzheimer’s Day 2026 highlights why early diagnosis matters as new Alzheimer’s treatments emerge and timely care becomes increasingly important.
Ayurveda needs stronger research, scientific validation, and safety monitoring to build a credible pipeline from traditional knowledge to market-ready products.
Congo's Ebola vaccination drive is testing how quickly pharma can turn vaccine research into real-world outbreak protection.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")